Abacus Health Products Inc (OTCMKTS:ABAHF – Get Free Report)’s stock price fell 5.1% during trading on Tuesday . The company traded as low as $4.60 and last traded at $4.84. 9,300 shares traded hands during trading, a decline of 9% from the average session volume of 10,164 shares. The stock had previously closed at $5.10.
Abacus Health Products Stock Down 5.1%
The stock has a fifty day moving average of $4.84 and a two-hundred day moving average of $4.84.
About Abacus Health Products
Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.
Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.
Further Reading
- Five stocks we like better than Abacus Health Products
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Abacus Health Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Health Products and related companies with MarketBeat.com's FREE daily email newsletter.
